Sonoma Pharmaceuticals In...

NASDAQ: SNOA · Real-Time Price · USD
5.32
0.05 (0.95%)
At close: Aug 15, 2025, 3:59 PM
5.20
-2.26%
After-hours: Aug 15, 2025, 07:58 PM EDT

Sonoma Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Net Income
-3.56M -3.46M -3.75M -3.69M -4.56M -4.83M -5.08M -6.15M -5.68M -5.15M -6.79M -5.79M -4.88M -5.09M -5.8M -5.51M -6.04M -3.95M -1.66M -2.1M -2.67M
Depreciation & Amortization
135K 138K 148K 160K 170K 176K 169K 156K 139K 125K 140K 145K 169K 186K 177K 220K 222K 227K 287K 275K 289K
Stock-Based Compensation
174K 224K 203K 330K 446K 516K 547K 649K 632K 669K 781K 595K 537K 382K 225K 262K 367K 371K 618K 637K 610K
Other Working Capital
1.03M 2.01M 3.02M 3.4M 2.21M 2.16M 93K -233K 220K -1.13M 738K 1.05M 460K 1.42M 1.34M 436K 1.01M -363K -1.54M -1.4M -2.15M
Other Non-Cash Items
483K 986K 973K 1.12M 216K -207K -504K -446K 1.21M 821K -1.03M -1.38M -3.62M -2.61M -1.26M -2.01M -1.93M -3.05M -3.19M -2.48M -1.04M
Deferred Income Tax
328K 357K -32K -65K -77K -109K 298K 147K 133K 3K -1.03M -829K -869K -829K -753K -753K n/a n/a 753K 753K n/a
Change in Working Capital
1.24M 1.66M 2.62M 634K 710K 1.69M -793K 1.04M -122K -1.86M 2.75M 2.11M 2.51M 3.13M 2.58M 3.13M 3.67M 1.38M -3.19M -4.35M -4.2M
Operating Cash Flow
-1.19M -88K 159K -1.51M -3.1M -2.4M -4.99M -4.24M -4.83M -6.15M -5.11M -5.08M -4.56M -4.25M -4.33M -3.26M -2.32M -3.38M -5.49M -7.08M -7.61M
Capital Expenditures
-181K -80K -30K -29K -5K -17K -210K -240K -263K -269K -141K -111K -111K -137K -80K -156K -176K -179K -294K -226K -246K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -610K -610K -610K -610K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 15K 15K 15K 15K 108K 173K 11K 11K -96K -160K 38K 38K 38K 31K -39K 567K 4.37M 4.41M 4.46M
Investing Cash Flow
-181K -80K -15K -14K 10K -2K -102K -67K -252K -258K -237K -320K -122K -148K -91K -125K -215K 388K 4.07M 4.19M 4.21M
Debt Repayment
-366K -404K -417K -463K -470K -481K 28K -73K -159K -379K -572K -542K -327K -176K -206K -56K -272K 1.02M 829K 772K 883K
Common Stock Repurchased
n/a n/a n/a 5K 5K n/a n/a -5K -5K n/a -206K -206K -206K -216K -10K -10K -10K n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
3.43M 3.43M 411K 410K 385K 373K 2.95M 2.86M 2.9M 2.87M -89K n/a 6.88M 6.91M 6.99M 7.28M 787K 2.29M 1.86M 1.57M 1.14M
Financial Cash Flow
2.34M 3.03M 3.41M 4.02M 2.45M 1.68M 4.43M 2.79M 2.74M 2.49M -661K 120K 7.22M 7.4M 7.44M 7.22M 515K 3.31M 3.04M 4.07M 3.75M
Net Cash Flow
1.02M 2.25M 2.83M 1.94M -955K -692K -228K -1.21M -2.04M -3.58M -5.89M -5.04M 2.77M 3.18M 2.99M 4.07M -1.74M 529K 1.81M 1.09M 267K
Free Cash Flow
-1.37M -168K 129K -1.54M -3.1M -2.42M -5.2M -4.47M -5.1M -6.42M -5.25M -5.2M -4.67M -4.38M -4.41M -3.41M -2.5M -3.56M -5.79M -7.3M -7.86M